Tibet Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the research, development, manufacturing and marketing of modernized traditional Tibetan medicines. The company employs 190 full-time employees The company went IPO on 2011-01-25. The firm sells both prescription and over-the-counter traditional Tibetan medicines. As of December 31, 2009, it had developed five pharmaceutical products. The firm sells its products principally to distributors in People's Republic of China, who in turn sell them to hospitals, hospital pharmacies and retail pharmacies. The Company’s products include 25 Ingredients Mandrake Pill, 28 Ingredients Pinang Pill, 18 Ingredients Chebulic (Myrobalan) Frusemide Pill, 15 Ingredients Gentiana Pill and Pomegranate Nichirin Pill.
Follow-Up Questions
What is Tibet Pharmaceuticals Inc (TBET)'s P/E Ratio?
The P/E ratio of Tibet Pharmaceuticals Inc is 0
Who is the CEO of Tibet Pharmaceuticals Inc?
Hong Yu is the Chairman of the Board of Tibet Pharmaceuticals Inc, joining the firm since 2010.
What is the price performance of TBET stock?
The current price of TBET is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Tibet Pharmaceuticals Inc?
Tibet Pharmaceuticals Inc belongs to Pharmaceuticals industry and the sector is Health Care
What is Tibet Pharmaceuticals Inc market cap?
Tibet Pharmaceuticals Inc's current market cap is $0
